Production (Stage)
Sanara MedTech Inc.
SMTI
$29.00
-$0.31-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.65% | 33.36% | 24.66% | 21.42% | 26.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.65% | 33.36% | 24.66% | 21.42% | 26.98% |
| Cost of Revenue | 6.14% | 3.66% | -8.95% | -16.53% | -0.84% |
| Gross Profit | 38.25% | 37.45% | 29.89% | 28.09% | 31.64% |
| SG&A Expenses | 32.11% | 30.37% | 25.27% | 20.73% | 21.21% |
| Depreciation & Amortization | 10.84% | 20.17% | 29.90% | 33.99% | 35.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.56% | 27.40% | 19.53% | 14.24% | 17.22% |
| Operating Income | 16.05% | 23.13% | 19.10% | 29.26% | 30.57% |
| Income Before Tax | -131.76% | -123.25% | -1.59% | 36.20% | 58.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -131.76% | -123.25% | -1.59% | 23.81% | 18.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 59.68% | 80.98% | -33.99% | -37.47% | -19.76% |
| Net Income | -133.72% | -124.59% | -2.33% | 23.50% | 18.32% |
| EBIT | 16.05% | 23.13% | 19.10% | 29.26% | 30.57% |
| EBITDA | 46.01% | 63.02% | 52.95% | 59.89% | 55.05% |
| EPS Basic | -128.37% | -118.26% | 1.25% | 26.08% | 19.84% |
| Normalized Basic EPS | -25.41% | -7.11% | -2.68% | 17.05% | 26.80% |
| EPS Diluted | -128.37% | -118.26% | 1.25% | 26.08% | 20.80% |
| Normalized Diluted EPS | -25.41% | -7.11% | -2.68% | 17.05% | 25.73% |
| Average Basic Shares Outstanding | 2.18% | 2.48% | 2.86% | 3.00% | 3.64% |
| Average Diluted Shares Outstanding | 2.18% | 2.48% | 2.86% | 3.00% | 2.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |